These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Dynamics of cancerous tissue correlates with invasiveness. West AV; Wullkopf L; Christensen A; Leijnse N; Tarp JM; Mathiesen J; Erler JT; Oddershede LB Sci Rep; 2017 Mar; 7():43800. PubMed ID: 28262796 [TBL] [Abstract][Full Text] [Related]
10. Hypoxia and loss of PHD2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasis. Madsen CD; Pedersen JT; Venning FA; Singh LB; Moeendarbary E; Charras G; Cox TR; Sahai E; Erler JT EMBO Rep; 2015 Oct; 16(10):1394-408. PubMed ID: 26323721 [TBL] [Abstract][Full Text] [Related]
11. Fibrosis and cancer: A strained relationship. Piersma B; Hayward MK; Weaver VM Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188356. PubMed ID: 32147542 [TBL] [Abstract][Full Text] [Related]
12. Tumor lineage-specific immune response in brain metastatic disease: opportunities for targeted immunotherapy regimen? Najjary S; Kros JM; de Koning W; Vadgama D; Lila K; Wolf J; Mustafa DAM Acta Neuropathol Commun; 2023 Apr; 11(1):64. PubMed ID: 37061716 [TBL] [Abstract][Full Text] [Related]
13. IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression. Sadik A; Somarribas Patterson LF; Öztürk S; Mohapatra SR; Panitz V; Secker PF; Pfänder P; Loth S; Salem H; Prentzell MT; Berdel B; Iskar M; Faessler E; Reuter F; Kirst I; Kalter V; Foerster KI; Jäger E; Guevara CR; Sobeh M; Hielscher T; Poschet G; Reinhardt A; Hassel JC; Zapatka M; Hahn U; von Deimling A; Hopf C; Schlichting R; Escher BI; Burhenne J; Haefeli WE; Ishaque N; Böhme A; Schäuble S; Thedieck K; Trump S; Seiffert M; Opitz CA Cell; 2020 Sep; 182(5):1252-1270.e34. PubMed ID: 32818467 [TBL] [Abstract][Full Text] [Related]
14. DrugBank 5.0: a major update to the DrugBank database for 2018. Wishart DS; Feunang YD; Guo AC; Lo EJ; Marcu A; Grant JR; Sajed T; Johnson D; Li C; Sayeeda Z; Assempour N; Iynkkaran I; Liu Y; Maciejewski A; Gale N; Wilson A; Chin L; Cummings R; Le D; Pon A; Knox C; Wilson M Nucleic Acids Res; 2018 Jan; 46(D1):D1074-D1082. PubMed ID: 29126136 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas. Yan D; Kowal J; Akkari L; Schuhmacher AJ; Huse JT; West BL; Joyce JA Oncogene; 2017 Oct; 36(43):6049-6058. PubMed ID: 28759044 [TBL] [Abstract][Full Text] [Related]
17. Advances in the Molecular Landscape of Lung Cancer Brain Metastasis. Souza VGP; de Araújo RP; Santesso MR; Seneda AL; Minutentag IW; Felix TF; Hamamoto Filho PT; Pewarchuk ME; Brockley LJ; Marchi FA; Lam WL; Drigo SA; Reis PP Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765679 [TBL] [Abstract][Full Text] [Related]
18. Microenvironment and the progress of immunotherapy in clinical practice of NSCLC brain metastasis. Xie M; Su C Front Oncol; 2022; 12():1006284. PubMed ID: 36761422 [TBL] [Abstract][Full Text] [Related]
19. The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis. Zhang Q; Abdo R; Iosef C; Kaneko T; Cecchini M; Han VK; Li SS Nat Commun; 2022 Oct; 13(1):5983. PubMed ID: 36216799 [TBL] [Abstract][Full Text] [Related]
20. Fibrous stroma: Driver and passenger in cancer development. Sharma V; Letson J; Furuta S Sci Signal; 2022 Mar; 15(724):eabg3449. PubMed ID: 35258999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]